Surrozen Financials

SRZN Stock  USD 9.88  0.12  1.23%   
Based on the analysis of Surrozen's profitability, liquidity, and operating efficiency, Surrozen is not in a good financial situation at this time. It has a very high odds of going through financial crisis in November. At this time, Surrozen's Non Currrent Assets Other are very stable compared to the past year. As of the 19th of October 2024, Cash And Short Term Investments is likely to grow to about 64.2 M, while Other Current Liabilities is likely to drop about 3.3 M. Key indicators impacting Surrozen's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.170.0891
Way Up
Slightly volatile
Current Ratio7.995.7543
Significantly Up
Pretty Stable
The essential information of the day-to-day investment outlook for Surrozen includes many different criteria found on its balance sheet. An individual investor should monitor Surrozen's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Surrozen.

Net Income

(45.19 Million)

  
Understanding current and past Surrozen Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Surrozen's financial statements are interrelated, with each one affecting the others. For example, an increase in Surrozen's assets may result in an increase in income on the income statement.

Surrozen Stock Summary

Surrozen competes with Bolt Biotherapeutics, Larimar Therapeutics, Keros Therapeutics, Kezar Life, and Processa Pharmaceuticals. Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California. Consonance-Hfw Acq operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 83 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS86889P1093
CUSIP86889P109 G2445M103 86889P208
LocationCalifornia; U.S.A
Business Address171 Oyster Point
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.surrozen.com
Phone650 489 9000
CurrencyUSD - US Dollar

Surrozen Key Financial Ratios

Surrozen Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Surrozen's current stock value. Our valuation model uses many indicators to compare Surrozen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Surrozen competition to find correlations between indicators driving Surrozen's intrinsic value. More Info.
Surrozen is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Surrozen's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Surrozen's earnings, one of the primary drivers of an investment's value.

Surrozen Systematic Risk

Surrozen's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Surrozen volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Surrozen correlated with the market. If Beta is less than 0 Surrozen generally moves in the opposite direction as compared to the market. If Surrozen Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Surrozen is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Surrozen is generally in the same direction as the market. If Beta > 1 Surrozen moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Surrozen Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Surrozen's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Surrozen growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(0.005334)

At this time, Surrozen's Price Earnings To Growth Ratio is very stable compared to the past year.

Surrozen October 19, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Surrozen help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Surrozen. We use our internally-developed statistical techniques to arrive at the intrinsic value of Surrozen based on widely used predictive technical indicators. In general, we focus on analyzing Surrozen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Surrozen's daily price indicators and compare them against related drivers.
When determining whether Surrozen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Surrozen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Surrozen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Surrozen Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surrozen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
To learn how to invest in Surrozen Stock, please use our How to Invest in Surrozen guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surrozen. If investors know Surrozen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surrozen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(22.49)
Revenue Per Share
6.017
Return On Assets
(0.43)
Return On Equity
(1.75)
The market value of Surrozen is measured differently than its book value, which is the value of Surrozen that is recorded on the company's balance sheet. Investors also form their own opinion of Surrozen's value that differs from its market value or its book value, called intrinsic value, which is Surrozen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surrozen's market value can be influenced by many factors that don't directly affect Surrozen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surrozen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Surrozen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surrozen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.